| CLASS | ABXBACT | LP7755-4 | 
| COMPONENT | Viomycin | LP16733-5 | 
| PROPERTY | Susc | LP6870-2 | 
| TIME_ASPCT | Pt | LP6960-1 | 
| SYSTEM | Isolate | LP7370-2 | 
| SCALE_TYP | Qn | LP7753-9 | 
| METHOD_TYP | MLC | LP6402-4 | 
| parent | Viomycin | Isolate | Antibiotic susceptibilities | LP380940-9 | 
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Observation | |
| UNITSREQUIRED | Y | |
| STATUS | ACTIVE | 
| LONG_COMMON_NAME | en-US | Viomycin [Susceptibility] by Minimum lethal concentration (MLC) | 
| LONG_COMMON_NAME | en-US | Viomycin [Susceptibility] by Minimum lethal concentration (MLC) | 
| SHORTNAME | en-US | Viomycin Islt MLC | 
| ConsumerName | en-US | Susceptibility to Viomycin | 
| SHORTNAME | es-AR | viomicina:susceptibilidad:punto en el tiempo:cepa clínica:cuantitativo:concentración letal mínima | 
| SHORTNAME | pt-BR | Viomycin Islt MLC | 
| LONG_COMMON_NAME | nl-NL | Viomycine [gevoeligheid] in isolaat d.m.v. minimaal dodelijke concentratie | 
| LONG_COMMON_NAME | es-MX | Viomicina: Aislado : Punto temporal: Susceptibilidad (microorganismos): Cuantitativo: Concentración mínima letal (MLC) | 
LOINC Version: 2.78